SCM
DXCM icon

Shelton Capital Management’s DexCom DXCM Stock Holding History

Shelton Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.48M Sell
55,485
-918
-2% -$63.9K 0.08% 175
2025
Q4 		$3.74M Buy
56,403
+10,295
+22% +$666K 0.07% 181
2025
Q3 		$3.1M Sell
46,108
-16,311
-26% -$1.29M 0.07% 183
2025
Q2 		$5.45M Sell
62,419
-2,222
-3% -$174K 0.13% 149
2025
Q1 		$4.41M Sell
64,641
-1,743
-3% -$142K 0.11% 163
2024
Q4 		$5.16M Buy
66,384
+15
+0% +$1.11K 0.13% 150
2024
Q3 		$4.45M Buy
66,369
+16,025
+32% +$1.32M 0.11% 162
2024
Q2 		$5.71M Buy
50,344
+2,048
+4% +$259K 0.16% 136
2024
Q1 		$6.7M Buy
48,296
+727
+2% +$91.4K 0.19% 125
2023
Q4 		$5.9M Buy
47,569
+4,052
+9% +$414K 0.19% 133
2023
Q3 		$4.06M Buy
43,517
+9,340
+27% +$1.05M 0.15% 165
2023
Q2 		$4.39M Buy
34,177
+1,329
+4% +$161K 0.16% 137
2023
Q1 		$3.82M Buy
32,848
+2,380
+8% +$266K 0.16% 140
2022
Q4 		$3.45M Sell
30,468
-6,552
-18% -$719K 0.36% 86
2022
Q3 		$2.98M Buy
37,020
+1,220
+3% +$103K 0.14% 158
2022
Q2 		$2.67M Hold
35,800
– – 0.12% 180
2022
Q1 		$4.58M Hold
35,800
– – 0.17% 134
2021
Q4 		$4.81M Buy
35,800
+1,316
+4% +$189K 0.17% 134
2021
Q3 		$4.71M Buy
34,484
+808
+2% +$102K 0.18% 122
2021
Q2 		$3.6M Hold
33,676
– – 0.14% 167
2021
Q1 		$3.03M Buy
33,676
+3,080
+10% +$289K 0.11% 189
2020
Q4 		$2.83M Buy
30,596
+1,180
+4% +$105K 0.13% 165
2020
Q3 		$3.03M Hold
29,416
– – 0.13% 185
2020
Q2 		$2.98M Buy
+29,416
New +$2.63M 0.16% 121

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Shelton Capital Management's DXCM Position: Q1 2026 in Review

Shelton Capital Management reduced its DexCom (DXCM) stake by 1.6% in Q1 2026, selling an estimated $63.9K and leaving 55,485 shares worth $3.48M. The position accounts for 0.08% of the portfolio, ranked #175.

Shelton Capital Management first reported a position in DXCM in Q2 2020 and has held it in 24 quarters since. The position peaked at $6.7M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Shelton Capital Management held 55,485 shares of DexCom worth $3.48M as of Q1 2026.
  • Shelton Capital Management sold 918 DexCom shares in Q1 2026, an estimated $63.9K.
  • DexCom made up 0.08% of Shelton Capital Management's portfolio in Q1 2026, its #175 holding.
  • Shelton Capital Management first reported a position in DexCom in Q2 2020 and has held it in 24 quarters since.
  • Shelton Capital Management's DexCom position peaked at $6.7M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Shelton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.